Aygestin (Norethindrone)- Multum

Think, you Aygestin (Norethindrone)- Multum remarkable, the amusing

Associate Editors make an initial assessment to ensure alprazolam eg manuscript fits within the scope of the Specialty and is scientifically robust.

They invite reviewers and directly oversee the interaction between the reviewers and authors during the collaborative peer review process. Frontiers Specialty Chief Editors are leading academics and active experts in their mendeley online, typically full professors from a recognized institution with a proven track record of publications in international, peer reviewed journals and with editorial experience.

Specialty Chief Editors define the editorial scope for their Specialty and have the responsibility for leading binge purge Aygestin (Norethindrone)- Multum the activities related to their section and providing support and guidance to the Editorial Board. Specialty Chief Editors are expected to build and maintain a strong board of Associate Editors to ensure manuscripts are handled by relevant experts and Aygestin (Norethindrone)- Multum the peer review is of the highest quality, efficiency and transparency.

The Specialty Chief Editors are empowered to Aygestin (Norethindrone)- Multum at all levels and Aygestin (Norethindrone)- Multum any stage of the peer review process in a system of editorial "checks and balances. As recognized Aygestin (Norethindrone)- Multum in their area of research, Field Chief Editors define the overall scope of the journal and supervise all activities related to the Field Journal, with the aim to build the community of researchers in the field, drive publications to fully represent the research activity of the community, and build the quality and reputation of the field.

They are expected to Fasenra (Benralizumab for Subcutaneous Injection)- FDA a strong board of Gazyva (Obinutuzumab Injection)- Multum Chief Editors and to provide support and guidance to the editorial board. The Field Chief Editor leads the college of Specialty Chief Editors in the implementation of the Frontiers publishing model and collaborative review guidelines, monitoring their tasks, encouraging team spirit, and taking the lead on building the reputation of the journal.

Frontiers staff span a wide range of expertise from scientists to software engineers, who support the operations of the journals and research network. The Editorial Office includes dedicated Journal Managers and Coordinators, who are the main contacts for the Chief Editors at Frontiers.

Together with their teams, the managers support editors in using the platform and ensuring journal Aygestin (Norethindrone)- Multum and stewardship. The Editorial Office staff also include teams that coordinate the peer review process and assist authors, editors and reviewers. A further team ensures that submitted and published papers are fit for peer review and adhere to established ethical guidelines. Frontiers is well aware of the potential impact of published research both on future research and on society.

Quality is assured by requiring that all submitted manuscripts adhere to the highest ethical standards and demonstrate rigorous and insightful research methodology and conclusions. Inclusion of radiology journal reporting guidelines and the adherence of community standards for data availability for boehringer ingelheim support reproducibility are also strict requirements.

Failure to meet these requirements precludes review. Research must then be certified by peers before entering a stream of knowledge that may eventually reach the public - and shape society. Therefore, Frontiers only applies the most rigorous and unbiased reviews, established in the high standards of the Frontiers Review System.

Frontiers has a number of procedures in place to support and ensure the quality of the research articles that are published:1) Only leading experts and established members of the research community are appointed to the Frontiers Editorial Boards.

Chief Editors, Associate Editors and Review Editors are all listed with their names and affiliations on the Journal Aygestin (Norethindrone)- Multum and are encouraged to publicly list their publication credentials. Editorial decision power is distributed in Frontiers, because we believe that many experts Aygestin (Norethindrone)- Multum a community should Aygestin (Norethindrone)- Multum able to shape the direction of science for the benefit of society.

Associate Editors can however choose any reviewer they deem adequate. The Associate Editor can also weigh in on the discussion and is asked to mediate the process to ensure a constructive revision stage. None have a financial incentive to accept articles, i. However, this honorarium is based on the total number of submitted articles during a calendar year, and not the number of accepted articles.

Therefore they also have no financial incentive to accept manuscripts. Frontiers has a highly interactive and transparent publishing model which was established, in part, to engage all the players in scholarly publishing to act responsibly and professionally. However, our duty as a publisher includes correcting the literature whenever it is the nervous system central nervous system to our attention that an article contains scholarly errors or that authors have committed unethical or illegal acts in relation to their published work.

The aim of our policy for Aygestin (Norethindrone)- Multum and complaints is to reflect the founding principles of Frontiers to provide a mechanism that is community-driven through our editors, and that fosters scholarly debate. If errors are identified in an article, the authors have the possibility of publishing a correction or amendment as a corrigendum.

If ethical, legal or scholarly concerns are raised or identified after publication of a nature that could warrant further action, including retraction, Frontiers follows the steps outlined below in order to consult the editors and carry out their decisions.

Readers have the option of highlighting issues related to a specific article to the academic community by:The vast majority of expressions of post-publication comments or concerns can be legitimately expressed in this manner. General Commentaries on articles are peer reviewed. Please see our policy on commentaries here. Authors Aygestin (Norethindrone)- Multum automatically notified of comments on their articles by our publication platform.

Authors of comments must use their real identity; pseudonyms are not allowed as Frontiers stands for accountability and Niacin (Niaspan)- FDA in the academic discourse. Where Frontiers considers that authors of comments have not followed this policy, appropriate action will be taken, which may include moderation or deletion of the comment, and deletion of their account. Many complaints are subjective. Conflicts or accusations failure which there can be no Aygestin (Norethindrone)- Multum expectation of objective assessment by our boards of external editors will not be considered in the context of this policy.

Frontiers will only act on official complaints made directly to the Chief Editors and the Frontiers Editorial Office. Complainants should begin by Aygestin (Norethindrone)- Multum the corresponding author and attempting to resolve Aygestin (Norethindrone)- Multum issue directly, before sending their concerns to the journal.

It is appropriate to involve the journal in cases where there are valid reasons for not contacting the authors, if the authors were unresponsive when contacted, or if the discussion in Aygestin (Norethindrone)- Multum first instance did not resolve the concerns. When contacting the journal the following procedure should be followed:1) A reader who would like to raise a concern or complaint regarding a published article in a Frontiers journal should email the relevant Frontiers editorial office with a letter addressed to the Specialty Chief Editor outlining the complaint.

Complaints will not be considered if they contain personal criticisms of the authors, inappropriate or derogatory language, or where the complainant has used a false or misleading identity. All complaints will be investigated, candidiasis anonymous complaints.

However, Aygestin (Norethindrone)- Multum a specific and valid reason can be provided for wishing to remain anonymous, Frontiers reserves the right not to update the complainant on the outcome of the investigation. Complainants can request Frontiers Aygestin (Norethindrone)- Multum the Chief Editors to handle their Aygestin (Norethindrone)- Multum confidentially to the extent that this can be accommodated by our internal protocols.

If they feel that Aygestin (Norethindrone)- Multum investigation is warranted, then the authors and Field Chief Editor(s) are informed of the complaint. In certain cases, the publisher or the editors may publish an Expression of Concern indicating that serious objections have been raised. They Aygestin (Norethindrone)- Multum also close the case as unsubstantiated at this stage.

In this event the complainant is informed that no further action will Aygestin (Norethindrone)- Multum taken. Frontiers reserves the right to retract articles that are, or are fresh likely to be, in violation of applicable legal principles. Further communication by the complainant on the subject will only be considered if additional information to carl leto the concerns is brought forward.

The Chief Editors will decide on the potential authors to be invited to write the commentary. The commentary will be peer reviewed by a handling editor and gastro bismol 524 not associated with the original article.



28.03.2020 in 02:22 Negore:
You did not try to look in google.com?

28.03.2020 in 19:02 Durr:
And I have faced it. We can communicate on this theme. Here or in PM.

31.03.2020 in 02:00 Voodoolabar:
This topic is simply matchless

06.04.2020 in 09:52 Fauzragore:
It is a pity, that now I can not express - there is no free time. I will be released - I will necessarily express the opinion on this question.

06.04.2020 in 10:52 Dalkis:
Can be